Cefdinir recalls
The FDA has published 11 recalls involving Cefdinir since 2013. The latest was reported on 5 Jun 2024. Most were for packaging defects. Lupin Pharmaceuticals has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls 11 since 2013
Last 12 months 0 reported
Class I 0 0% of total
Ongoing 0 latest 5 Jun 2024
Recalls per month, last 24 months click a bar for that month Severity split
0 0%9 82%2 18%
All cefdinir recalls, newest first 11 total Reported Class Recall Company Reason Where 5 Jun 2024 Drug CLASS II Cefdinir for Oral Suspension USP, 250 mg recalled Cefdinir Lupin Pharmaceuticals Packaging Defects Nationwide 22 May 2024 Drug CLASS II Cefdinir for Oral Suspension USP 125 mg/ when reconstituted) recalled Cefdinir Lupin Pharmaceuticals Foreign Material Nationwide 22 May 2024 Drug CLASS II Cefdinir for Oral Suspension USP 250 mg/ when reconstituted) recalled Cefdinir Lupin Pharmaceuticals Foreign Material Nationwide 29 Jul 2020 Drug CLASS II Cefdinir for Oral Suspension USP, 250 mg recalled Cefdinir Lupin Pharmaceuticals Potency & Assay Nationwide 13 Nov 2019 Drug CLASS III Cefdinir for Oral Suspension USP, 125 mg recalled Cefdinir Lupin Pharmaceuticals Packaging Defects Nationwide 13 Nov 2019 Drug CLASS III Cefdinir for Oral Suspension USP, 250 mg recalled Cefdinir Lupin Pharmaceuticals Other Nationwide 5 Jun 2019 Drug CLASS II Cefdinir for Oral Suspension USP, 250mg/, Powder for oral suspension recalled Cefdinir Lupin Pharmaceuticals Foreign Material Nationwide 16 Jan 2019 Drug CLASS II Cefdinir for Oral Suspension USP, 250mg recalled Cefdinir Lupin Pharmaceuticals Manufacturing (CGMP) Deviations Nationwide 16 Jan 2019 Drug CLASS II Cefdinir for Oral Suspension USP, 125mg recalled Cefdinir Lupin Pharmaceuticals Manufacturing (CGMP) Deviations Nationwide 25 Apr 2018 Drug CLASS II Lupin Cefdinir powder for Oral Suspension USP, 250 mg recalled Cefdinir Lupin Pharmaceuticals Potency & Assay Nationwide 17 Apr 2013 Drug CLASS II Cefdinir for Oral Suspension, 125 mg recalled Cefdinir Teva Pharmaceuticals USA Packaging Defects Nationwide
Should you stop taking Cefdinir?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.